Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Klein, Catherine J. 2002. Nutrient Requirements For Preterm Infant Formulas. The Journal of Nutrition, Vol. 132, Issue. 6, p. 1395S.
Northrop-Clewes, C.A. and Thurnham, D.I. 2002. The Nutrition Handbook for Food Processors. p. 34.
Moat, Stuart J Ashfield-Watt, Pauline A L Powers, Hilary J Newcombe, Robert G and McDowell, Ian F W 2003. Effect of Riboflavin Status on the Homocysteine-lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype. Clinical Chemistry, Vol. 49, Issue. 2, p. 295.
Jacobs, Peter and Wood, Lucille 2003. Vitamin B2. Disease-a-Month, Vol. 49, Issue. 11, p. 653.
Perumal, Selvanathan Saravana Shanthi, Palanivelu and Sachdanandam, Panchanadham 2005. Energy-modulating vitamins – a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. British Journal of Nutrition, Vol. 93, Issue. 6, p. 901.
Bates, C.J. 2005. Encyclopedia of Human Nutrition. p. 100.
Compher, Charlene 2005. Clinical Nutrition. p. 126.
Graham, Joanne M Peerson, Janet M Haskell, Marjorie J Shrestha, Ram K Brown, Kenneth H and Allen, Lindsay H 2005. Erythrocyte Riboflavin for the Detection of Riboflavin Deficiency in Pregnant Nepali Women. Clinical Chemistry, Vol. 51, Issue. 11, p. 2162.
Perumal, Selvanathan Saravana Shanthi, Palanivelu and Sachdanandam, Panchanadham 2005. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer. Cancer Chemotherapy and Pharmacology, Vol. 56, Issue. 1, p. 105.
Yuvaraj, Srinivasan Premkumar, Vummidi Giridhar Vijayasarathy, Kothandaraman Gangadaran, Sitthu Govindaswamy Dinakaran and Sachdanandam, Panchanatham 2008. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. Cancer Chemotherapy and Pharmacology, Vol. 61, Issue. 6, p. 933.
Almeida, Lana Carneiro Tomita, Luciana Yuki D'Almeida, Vânia and Cardoso, Marly Augusto 2008. Preditores sócio-demográficos, de estilo de vida e gineco-obstétricos das concentrações séricas ou plasmáticas de homocisteína, ácido fólico e vitaminas B12 e B6 em mulheres de baixa renda de São Paulo, Brasil. Cadernos de Saúde Pública, Vol. 24, Issue. 3, p. 587.
Tucker, K.L. 2009. Food for the Ageing Population. p. 399.
Yuvaraj, Srinivasan Premkumar, Vummidi Gridhar Shanthi, Palanivel Vijayasarathy, Kothandaraman Gangadaran, Sitthu Govindaswamy Dinakaran and Sachdanandam, Panchanatham 2009. Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Research and Treatment, Vol. 114, Issue. 2, p. 377.
Mushtaq, Sohail Su, Han Hill, Marilyn HE and Powers, Hilary J 2009. Erythrocyte pyridoxamine phosphate oxidase activity: a potential biomarker of riboflavin status?. The American Journal of Clinical Nutrition, Vol. 90, Issue. 5, p. 1151.
Hoey, Leane McNulty, Helene and Strain, JJ 2009. Studies of biomarker responses to intervention with riboflavin: a systematic review. The American Journal of Clinical Nutrition, Vol. 89, Issue. 6, p. 1960S.
Perlmutter, David 2009. Food and Nutrients in Disease Management.
ASH, ANTHONY and WILBEY, ANDREW 2010. The nutritional significance of cheese in the UK diet. International Journal of Dairy Technology, Vol. 63, Issue. 3, p. 305.
Petteys, Brian J. and Frank, Elizabeth L. 2011. Rapid determination of vitamin B2 (riboflavin) in plasma by HPLC. Clinica Chimica Acta, Vol. 412, Issue. 1-2, p. 38.
Sinigaglia-Coimbra, Rita Lopes, Antonio Carlos and Coimbra, Cicero G. 2011. Handbook of Behavior, Food and Nutrition. p. 2427.
Garrido‐Maraver, Juan Cordero, Mario D Moñino, Irene Domínguez Pereira‐Arenas, Sheila Lechuga‐Vieco, Ana V Cotán, David De la Mata, Mario Oropesa‐Ávila, Manuel De Miguel, Manuel Bautista Lorite, Juan Rivas Infante, Eloy Álvarez‐Dolado, Manuel Navas, Plácido Jackson, Sandra Francisci, Silvia and Sánchez‐Alcázar, José A 2012. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease. British Journal of Pharmacology, Vol. 167, Issue. 6, p. 1311.